Cause analysis and treatment of a case of subcutaneous injection of low molecular weight heparin calcium causing huge subcutaneous hematoma of the abdominal wall
1例皮下注射低分子肝素钙致腹壁皮下巨大血肿原因分析及处理

摘要

临床中对膝骨关节炎术后患者，术后VTE预成为围术期管理的重点，其中药物预防是预防VTE的主要措施之一，应用低分子肝素钙皮下注射治疗，较少出现并发症。但我科出现1例皮下注射低分子肝素钙致腹壁皮下巨大血肿患者，对发生腹壁皮下巨大血肿原因进行分析，包括（注射方法改进、支持心理护理、药物代谢速度、物理因素等）避免以后再次发生腹壁巨大血肿，并针对低分子肝素钙皮下注射发生腹壁皮下巨大血肿患者给予处理干预，提升临床腹壁皮下巨大血肿处理效果，以提升临床低分子肝素钙皮下注射疗效，确保患者治疗安全。

Abstract

In clinical practice, for patients with knee osteoarthritis after surgery, postoperative VTE prevention has become the focus of perioperative management, among which drug prevention is one of the main measures to prevent VTE. Subcutaneous injection of low molecular weight heparin calcium is used for treatment, and complications are less likely to occur. However, a patient with a huge subcutaneous hematoma of the abdominal wall caused by subcutaneous injection of low molecular weight heparin calcium occurred in our department. The causes of the huge subcutaneous hematoma of the abdominal wall were analyzed, including (improvement of injection method, supportive psychological care, drug metabolism rate, physical factors, etc.) to avoid the recurrence of huge subcutaneous hematoma of the abdominal wall in the future, and treatment intervention was given to patients with huge subcutaneous hematoma of the abdominal wall caused by subcutaneous injection of low molecular weight heparin calcium, so as to improve the clinical treatment effect of huge subcutaneous hematoma of the abdominal wall, so as to improve the clinical efficacy of subcutaneous injection of low molecular weight heparin calcium and ensure the safety of patient treatment.